How common is antimicrobial resistance in people with chronic lung diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter, international observational study that collects routine clinical and microbiology data from patients with chronic lung diseases over five years. Data are gathered during two two-week periods each year and include demographic, clinical, and microbiology variables, with records de-identified in a secure eCRF. No interventions beyond standard clinical practice are performed. The aim is to map the prevalence and burden of AMR locally and globally, explore susceptibility patterns of high priority pathogens, assess geographic variability, and identify risk factors for AMR in chronic lung disease patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients of all ages with any chronic lung disease who, for clinical practice, underwent testingof at least one respiratory biological sample (sputum culture; bronchoaspirate; bronchoalveolar lavage; nasal swab; throat swab) within the 12 months prior to the visit.
* Patients attending an outpatient clinic or hospitalized during the study period

Exclusion Criteria:

* Patients who have not signed the informed consent form
* Absence of data in the patient record

Where it's running

• University of Michigan
  Ann Arbor, Michigan, United States Recruiting
• Catholic University Our Lady of Good Counsel
  Tirana, Albania Recruiting
• Frankston Hospital
  Frankston, Australia Recruiting
• Antwerp University Hospital
  Antwerp, Belgium Recruiting
• CHU St Pierre
  Brussels, Belgium Recruiting
• AZ Maria Middelares
  Ghent, Belgium Recruiting

+18 more sites. See ClinicalTrials.gov for the full list.

Study contacts

• Principal investigator: Andrea Gramegna — Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano
• Study coordinator: Andrea Gramegna
• Email: andrea.gramegna@unimi.it
• Phone: 0255032020

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Observational look at antimicrobial resistance in people with chronic lung disease

  This study tests how antimicrobial resistance appears in people with chronic lung diseases like COPD or bronchiectasis by collecting samples and health data over time.

  Recruiting Imperial College London · London · NCT07646691

• Impact of a Clinical Information System on hospital outcomes for adults with chronic diseases

  This study tests whether implementing a Clinical Information System helps reduce readmissions or death within 30 days after hospital discharge for adults with chronic conditions in Alberta.

  Recruiting University of Calgary · Calgary, Alberta · NCT07609381

• PNEUMO-LIBS: Using tissue imaging and AI to explore causes of chronic lung diseases

  This study tests whether multi-element tissue imaging with LIBS, plus the AI tool IFF, can help doctors understand possible causes of chronic lung diseases in adults who have had a lung biopsy.

  Recruiting at 3 sites University Hospital, Grenoble · Grenoble and 2 other locations · NCT07597187

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.